Escherichia coli O157:H7 infection in humans

Annals of Internal Medicine

Volumn 123, Issue 9, 1995, Pages 698-714

  Su, Chinyu ^a,c   Brandt, Lawrence J ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN;

BACTERIAL INFECTION; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; FATALITY; FECES ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIC PURPURA; TREATMENT PLANNING;

EID: 0028828571     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-123-9-199511010-00009     Document Type: Review

References (217)

1. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Devis BR, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med. 1983;308:681-5.
2. Centers for Disease Control. Isolation of E. coli O157:H7 from sporadic cases of hemorrhagic colitis - United States. MMWR Morb Mortal Wkly Rep. 1982;31:580, 585.
3. MacDonald KL, O'Leary MJ, Cohen ML, Norris P, Wells JG, Noll E, et al. Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA 1988;259:3567-70.
4. Ostroff SM, Kobayashi JM, Lewis JH. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA. 1989;262:355-9.
5. Pai CH, Gordon R, Sims HV, Bryan LE. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med. 1984;101: 738-42.
6. Pai CH, Ahmed N, Lior H, Johnson WM, Sims HV, Woods DE. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis. 1988;157: 1054-7.
7. Ratnam S, March S. Sporadic occurrence of hemorrhagic colitis associated with Escherichia coli O157:H7 in Newfoundland. Can Med Assoc J. 1986;134:43-9.
8. Remis RS, MacDonald KL, Riley LW, Puhr ND, Wells JG, Davis BR, et al. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med. 1984;101:624-6.
9. Report from the PHLS Communicable Disease Surveillance Centre. BMJ. 1987;295:1545-6.
10. Belongia EA, MacDonald KL, Parbam GL, White KE, Korlath JA, Lobato MN, et al. An outbreak of Escherichia coli O157:H7 colitis associated with consumption of precooked meat patties. J Infect Dis. 1991;164:338-43.
11. Carter AO, Borezyk AA, Carlson JA, Harvey B, Hockin JC, Karmali MA, et al. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N Engl J Med. 1987;316:1496-500.
12. Dev VJ, Main M, Gould I. Waterborne outbreak of Escherichia coli O157 [Letter]. Lancet. 1991;337:1412.
13. Duncan L, Mai V, Carter A, Carlson JA, Borczyk AA, Karmali MA. Outbreak of gastrointestinal disease in Sarnia, Ontario. Ontario Disease Surveillance Report. 1986;7:604-11.
14. Centers for Disease Control. Foodborne outbreak of gastroenteritis caused by Escherichia coli O157:H7-North Dakota, 1990. MMWR Morb Mortal Wkly Rep. 1991;40:265-7.
15. Laboratory Center of Disease Control. Hemorrhagic colitis in a home for the aged - Ontario. Canada Diseases Weekly Report. 1983;9:29-32.
16. Ostroff SM, Griffin PM, Tauxe RV, Shipman LD, Greene KD, Wells JG, et al. A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol. 1990;132:239-47.
17. Laboratory Center of Disease Control. Outbreak of gastrointestinal disease - Ontario. Canada Diseases Weekly Report. 1987;13:5-8.
18. Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr. 1990;116:544-51.
19. Ryan CA, Tauxe RV, Hosek GW, Wells JG, Stoesz PA, McFadden HW Jr, et al. Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings. J Infect Dis. 1986; 154:631-8.
20. Spika JS, Parsons JE, Nordenberg D, Wells JG, Gunn RA, Blake PA. Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center. J Pediatr. 1986;109:287-91.
21. Rowe PC, Walop W, Lior H, Mackenzie AM. Haemolytic anaemia after childhood Escherichia coli O157:H7 infection: are females at increased risk? Epidemiol Infect. 1991;106:523-30.
22. Rowe PC, Orrbine E, Wells GA, McLaine PN. Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre. J Pediatr. 1991;119:218-24.
23. Lior H. Incidence of hemorrhagic colitis due to Escherichia coli in Canada. Can Med Assoc J. 1988;139:1073-4.
24. Swerdlow DL, Woodruff BA, Brady RC, Griffin PM, Tippen S, Donnell HD Jr, et al. A Waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann Intern Med. 1992;116:812-9.
25. Cahoon FE, Thompson JS. Frequency of Escherichia coli O157:H7 isolation from stool specimens. Can J Microbiol. 1987;33:914-5.
26. Gransden WR, Damm MA, Anderson JD, Carter JE, Lior H. Further evidence associating hemolytic-uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7. J Infect Dis. 1986; 154:522-4.
27. Johnson WM, Lior H, Bezanson GS. Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada [Letter]. Lancet. 1983;1:76.
28. Noda M. Yutsudo T, Nakabayashi N, Hirayama T, Takeda Y. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin. Microb Pathog. 1987;2:339-49.
29. O'Brien AD, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin [Letter]. Lancet. 1983;1:702.
30. O'Brien AD, Lively TA, Chang TW, Gorbach SL. Purification of Shigella dysenteriae 1 (Shiga)-like toxin from Escherichia coli O157:H7 strain associated with haemorrhagic colitis [Letter]. Lancet. 1983;2: 573.
31. Padhye VV, Beery JT, Kittell FB, Doyle MP. Colonic hemorrhage produced in mice by a unique vero cell cytotoxin from an Escherichia coli strain that causes hemorrhagic colitis. J Infect Dis. 1987;155: 1249-53.
32. Padhye VV, Kittell FB, Doyle MP. Purification and physicochemical properties of a unique Vero cell cytotoxin from Escherichia coli O157:H7. Biochem Biophys Res Commun. 1986;139:424-30.
33. Scotland SM, Smith HR, Rowe B. Two distinct toxins active on Vero cells from Escherichia coli O157 [Letter]. Lancet. 1985;2:885-6.
34. Strockbine NA, Marques LR, Newland JW, Smith HW, Holmes RK, O'Brien AD. Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun. 1986;53:135-40.
35. Levine MM. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis. 1987;155:377-89.
36. von Wulfen H, Russman H, Karch H, Meyer T, Bitzan M, Kohrt TC, et al. Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis (Letter). Lancet. 1989;1:1449-50.
37. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, et al. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med. 1988;109:705-12.
38. Hamano S, Nakanishi Y, Nara T, Seki T, Ohtani T, Oishi T, et al. Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infectior in Japan. Acta Paediatr. 1993;82: 454-8.
39. Kovacs MJ, Roddy J, Gregoire S, Cameron W, Eidus L, Drouin J. Thrombotic thrombocytopenic purpura following hemorrhagic colitis due to Escherichia coli O157:H7. Am J Med. 1990;88:177-9.
40. Morrison DM, Tyrrell DL, Jewell LD. Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP). Am J Clin Pathol. 1986;86:108-12.
41. Centers for Disease Control. Thrombotic thrombocytopenic purpura associated with Escherichia coli O157:H7-Washington. MMWR Morb Mortal Wkly Rep. 1986;35:549-51.
42. Riley LW. The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis. Annu Rev Microbiol. 1987;41:383-407.
43. Miller WT, De Poto DW, Scholl HW, Rafensperger EC. Evanescent colitis in the young adult: a new entity? Radiology. 1971;100:71-8.
44. Edelman R, Karmali MA, Fleming PA. From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. J Infect Dis. 1988;157:1102-4.
45. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. JAMA. 1993;269:883-8.
46. Fong JS, de Chadarevian JP, Kaplan BS. Hemorytic-uremic syndrome. Current concepts and management. Pediatr Clin North Am. 1982;29:835-56.
47. Kaplan BS, Proesmans W. The hemolytic-uremic syndrome of childhood and its variants. Semin Hematol. 1987;24:148-60.
48. Pickering LK, Obrig TG, Stapleton FB. Hemolytic-uremic syndrome and enterohemorrhagic Escherichia coli. Pediatr Infect Dis J. 1994;13: 459-75;quiz 476.
49. Levin M, Walters MD, Barratt TM. Hemolytic uremic syndrome. Adv Pediatr Infect Dis. 1989;4:51-81.
50. Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev. 1989;2:15-38.
51. Whitington PF, Friedman AL, Chesney RW. Gastrointestinal disease in the hemolytic-uremic syndrome. Gastroenterology. 1979;76:728-33.
52. Martin DL, MacDonald KL, White KE, Soler JT, Osterholm MT. The epidemiology and clinical aspects of the hemolytic-uremic syndrome in Minnesota. N Engl J Med. 1990;323:1161-7.
53. Bar-Ziv J, Ayoub JI, Fletcher BD. Hemolytic uremic syndrome: a case presenting with acute colitis. Pediatr Radiol. 1974;2:203-6.
54. Herman W Jr. The hemolytic-uremic syndrome: initial clinical presentation mimicking ulcerative colitis. J Pediatr. 1972;81:275-8.
55. Peterson RB, Meseroll WP, Shrago GG, Gooding CA. Radiographic features of colitis associated with the hemolytic-uremic syndrome. Radiology. 1976;118:667-71.
56. Sawaf H, Sharp MJ, Youn KJ, Jewell PA, Rabbani A. Ischemic colitis and stricture after hemolytic-uremic syndrome. Pediatrics. 1978;61: 315-7.
57. Schwartz DL, Becker JM, So HB, Schneider KM. Segmental colonic gangrene: a surgical emergency in the hemolytic-uremic syndrome. Pediatrics. 1978;62:54-6.
58. Cimolai N, Morrison BJ, Carter JE. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolyticuremic syndrome. Pediatrics. 1992;90:616-21.
59. Bale JF Jr, Brasher C, Siegler RL. CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child. 1980;134:869-72.
60. Gianantonio CA, Vitacco M, Mendilaharzu F, Gallo GE, Sojo ET. The hemolytic-uremic syndrome. Nephron. 1973;11:174-92.
61. Schlieper A, Rowe PC, Orrbine E, Zoubek M, Clark W, Wolfish N, et al. Sequalae of haemolytic uraemic syndrome. Arch Dis Child. 1992; 67:930-4.
62. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic-uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985; 151:775-82.
63. Neill MA, Tarr PI, Clausen CR, Christie DL, Hickman RO. Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic-uremic syndrome: a prospective study in the Pacific Northwest. Pediatrics. 1987;80:37-40.
64. Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, et al. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child. 1990;65:722-7.
65. Laboratory Centers for Disease Control. Enterohemorrhagic Escherichia coli and the hemolytic-uremic syndrome-the Alberta experience. Canada Diseases Weekly Report. 1989;15:9-12.
66. Neill MA, Tarr PI, Christie DL. Clinical findings in hemorrhagic colitis with Escherichia coli O157:H7. Gastroenterology. 1987;92:1551.
67. Scotland SM, Rowe B, Smith HR, Willshaw GA, Gross RJ. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol. 1988;25:237-43.
68. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983;1:619-20.
69. Isb-Shalom N, Arbus GS, Karmali MA. A family outbreak of hemolytic-uremic syndrome (hemolytic-uremic syndrome) affecting 5 siblings, associated with verotoxin (VT)-producing Escherichia coli (VTEC) O157:H7 [Abstract]. Pediatr Res. 1986;20:228A.
70. Laboratory Center for Disease Control Hemorrhagic colitis and hemolytic-uremic syndrome caused by Escherichia coli O157:H7 in Canada. Canada Diseases Weekly Report. 1987;13:203-4.
71. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic Escherichia coli, and the associated hemotytic-uremic syndrome. Epidemiol Rev. 1991;13:60-98.
72. Lopez EL, Dial M, Grinstein S, Devoto S, Mendilaharai F, Murray BE, et al. Hemolytic uremic syndrome and díarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis. 1989;160:469-75.
73. Neill MA, Agosti J, Rosen H. Hemorrhagic colitis with Escherichia coli O157:H7 preceding adult hemolytic-uremie syndrome. Arch Intern Med. 1985;145:2215-7.
74. Tarr PI, Neill MA, Allen J, Siccardi CJ, Watking SL, Hickman RO. The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias. Am J Epidemiol. 1989;129:582-6.
75. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic-uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis. 1990;162:553-6.
76. Milford DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthoos H. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Pan 1: Clinical and epidemiological aspects. Arch Dis Child. 1990;65:716-21.
77. Cimolai N, Carter JE, Morrison BJ, Anderson JD. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolyticuremic syndrome. J Pediatr. 1990; 116:589-92.
78. Cimolai N, Carter JE. Influence of antidiarrheal and antimicrobial medications on the hemorrhagic colitis associated with hemolyticuremic syndrome. J Pediatr. 1990;116:676.
79. Ashkenazi S, Cleary TG, Lopez E, Pickering LK, Anticytotoxinneutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. J Pediatr. 1988;113:1008-14.
80. Milford DV, Taylor CM, Rose PE, Roy TC, Rowe B. Immunologic therapy for hemolytic-uremic syndrome [Letter]. J Pediatr. 1989;115: 502-4.
81. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis. 1989;160:994-8.
82. Kwaan HC, Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol. 1987;24:71-81.
83. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore). 1981; 60:413-28.
84. Bell BP, Goldoft M, Griffin PM, Davis MA, Gordon DC, Tarr PI, et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic-uremie syndrome from hamburgers. JAMA. 1994;272:1349-53.
85. Keene WE, McAnulty JM, Hoesly FC, Williams LP Jr, Hedberg K, Oxman GL, et al. A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei. N Engl J Med. 1994;331:579-84.
86. Morgan GM, Newman C, Palmer SR, Allen JB, Shepherd W, Rampling AM, et al. First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O157:H7 in the UK, Epidemiol Infect. 1988;101:83-91.
87. From the Centers for Disease Control and Prevention. Update: multistate outbreak of Escherichia coli O157:H7 infections from hamburgers-western United States, 1992-1993. JAMA. 1993;269:2194-6.
88. Besser RE, Lett SM, Weber JT, Doyle MP, Barrett TJ, Wells JG, et al. An outbreak of diarrhea and hemolytic-uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA. 1993; 269:2217-20.
89. Smith HR, Rowe B, Gross RJ, Fry NK, Scotland SM. Hemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet. 1987;1:1062-4.
90. Albert MJ, Bettelheim KA. Enterohaemorrhagic E. coli O157:H7 in central Australia [Letter]. J Diarrhoeal Dis Res. 1989;7:96-7.
91. Browning NG, Botha JR, Sacho H, Moore PJ. Escherichia coli O157:H7 haemorrhagic colitis. Report of the first South African case. S Afr J Surg. 1990:28:28-9.
92. Caprioli A, Luzzi I, Rosmini F, Pasquini P, Cirrincione R, Gianviti A, et al. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. The HUS Italian Study Group. J Infect Dis. 1992;166:154-8.
93. Sramkova L, Bielaszewska M, Janda J, Blahova K. Hausner O. Vero cytotoxin-producing strains of Escherichia coli in children with haemolytic uraemic syndrome and diarrhoea in Czechoslovakia. Infection. 1990;18:204-9.
94. Cordovez A, Prado V, Maggi L, Cordero J, Martinez J, Misraji A, et al. Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children. J Clin Microbiol. 1992;30: 2153-7.
95. Ostroff SM, Hopkins DP, Tauxe RV, Sowers EG, Strockbine NK. Surveillance of Escherichia coli O157 isolation and confirmation, United States, 1988. MMWR CDC Surveill Summ. 1991;40:l-6.
96. Outbreak of bloody diarrhea caused by Escherichia coli O157:H7. Wisconsin Epidemiology Bulletin. 1988;10:l-2.
97. Martin ML, Sbipman LD, Wells JG, Potter ME, Hedberg K, Wachsmuth IK, et al. Isolation of Escherichia coli O1S7:H7 from dairy cattle associated with two cases of haemotytic uraemic syndrome [Letter], Lancet. 1986:2:1043.
98. Wells JG, Shipman LD, Grecae KD, Sowers EG, Green JH, Cameraon DN, et al. Isolation of Escherichia coli serotype O157:H7 and other Shiga-like-toxin-producing E. coli from dairy cattle. J Clin Microbiol. 1991;29:985-9.
99. Doyle MP, Schoeni JL. Isolation of Escherichia coli O157:H7 from retail fresh meats and poultry. Appl Environ Microbiol. 1987;53: 2394-6.
100. Ratnam S, March SB, Spragne WD. Are humans a source of Escherichia coli O157:H7, the agent of hemorrhagic colitis? [Letter] N Engl J Med. 1986;315:1612-3.
101. Karmali MA, Artus GS, Petric M, Patrick ML, Roscoe M. Shaw J, et al. Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse [Letter]. Lancet. 1988;1:526.
102. Yaonelli B, Domenico P, Cuoha BA, Qnadri SM. Nosocomial Escherichia coli O157:H7 diarrhea (Letter]. Am J Infect Control. 1990;18: 341-2.
103. Grifin PM, Olmstead LC, Petras RE. Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterology. 1990;99:142-9.
104. Kelly J, Oryshak A, Wenetsek M, Grabiec J, Handy S. The colonic pathology of Escherichia coli O157:H7 infection. Am J Surg Pathol. 1990:14:87-92.
105. Richardson SE, Karmali MA, Becker LE, Smith CR. The histopathology of the hemolytic-uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol. 1988;19: 1102-8.
106. Dalai BI, Krishnan C, Laschuk B, Duff JH. Sporadic hemorrhagic colitis associated with Escherichia coli, type O157:H7: unusual presentation mimicking ischemic colitis. Can J Surg. 1987;30:207-8.
107. Brandt LJ, Su C, Alt E, Sigal S, Patter-son K, Tarr PL Immunoper-oxidase tissue staining to diagnose E. coli O157:H7 infection: a cause of ischemic colitis [Abstract]. Gastroenterology. 1995;108:A787.
108. Scotland SM, Willshaw GA, Smith HR, Rowe B. Propenies of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2. Epidem Infect. 1987;99:613-24.
109. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun. 1977;18:775-9.
110. Lingwood CA, Law H, Richardson S, Petric M, Brunton JL, De Grandis S, et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem. 1987;262: 8834-9.
111. Waddell T, Head S, Petric M, Cohen A, Lingwood C. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun. 1988;152:674-9.
112. Boyd B, Lingwood C. Verotoxin receptor glycolipid in human renal tissue. Nephron. 1989;51:207-10.
113. Cohen A, Hannigan GE, Williams BR, Lingwood CA. Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem. 1987;262:17088-91.
114. Keenan KP, Sharpnack DD, Collins H, Formal SB, O'Brien AD. Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. Am J Pathol. 1986;125:69-80.
115. Wade WG, Thorn BT, Evans N. Cytotoxic enteropathogenic Escherichia coli. Lancet. 1979;2:1235-6.
116. Strockbine NA, Jackson MP, Sung LM, Holmes RK, O'Brien AD. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1. J Bacteriol. 1988;160:1115-22.
117. O'Brien AD, LaVeck GD. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun. 1983;40:675-83.
118. O'Brien AD, LaVeck GD, Thompson MR, Formal SB. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis. 1982;146:763-9.
119. Takao T, Tanabe T, Hong YM, Shimonishi Y, Kurazono H, Yutsudo T, et al. Identity of molecular structure of Shiga-like toxin (VT1) from Escherichia coli O157:H7 with that of Shiga toxin. Microb Pathog. 1988;5:57-69.
120. Calderwood SB, Anclair F, Donohue-Rolfe A, Keusch GT, Mekalanos JJ. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli. Proc Natl Acad Sci U S A. 1987:84:4364-8.
121. Jackson MP, Newland JW, Holmes RK, O'Brien AD. Nucleotide sequence analysis of the structural genes for Shiga-like toxin 1 encoded by bacteriophage 933J from Escherichia coli. Microb Pathog. 1987;2:147-53.
122. Ito H, Terai A, Kurazono H, Takeda Y, Nisbibucbi M. Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with hemolytic-uremic syndrome. Microb Pathog. 1990:8:47-60.
123. Jackson MP, Neill RJ, O'Brien AD, Holmes RK, Newland JW. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophage from Escherichia coll 933. FEMS Microbiol Lett. 1987;44:109-14.
124. Gyles CL. Escherichia coll cytotoxins and enterotoxins. Can J Microbiol. 1992;38:734-46.
125. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coll O157:H7 and Shiga toxin on eukaiyotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem. 1988;161:45-50.
126. Furutani M, Ho K, Oku Y, Takeda Y, Igarashi K. Demonstration of RNA N-glycosidase activity of a Vero toxin (VT2 variant) produced by Escherichia coli O91:H21 from a patient with the hemolytic-uremic syndrome. Microbiol Immunol. 1990;34:387-92.
127. Igarashi K, Ogasawara T, Ito K, Vutsudo T, Takeda Y. Inhibition of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes by Shiga-like toxin 1 (VT1) from Escherichia coli O157:H7 and by Shiga toxin. FEMS Microbiol Lett. 1987;44:91-4.
128. Ogasawara T, Ito K, Igarashi K, Yutsudo T, Nakabayashi N, Takeda Y. Inhibition of protein synthesis by a Vero toxin (VT2 or Shiga-like toxin II) produced by Escherichia coli O157:H7 at the level of elongation factor 1-dependent aminoacyl-tRNA binding to ribosomes. Microb Pathog. 1988;4:127-35.
129. O'Brien AD, Holmes RK, Shiga and Shiga-like toxins. Microbiol Rev. 1987;51:206-20.
130. O'Brien AO, Newland JW, Miller SF Holmes RK, Shiga-like toxinconverting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science. 1984;226:694-6.
131. Scotland SM, Smith HR, Willshaw GA, Rowe B. Vero cytotoxin production in strain of Escherichia coli is determined by genes carried on bacteriophage [Letter], Lancet. 1983;2:216.
132. Smith HR, Day NP, Scotland SM, Gross RJ, Rowe B. Phage-determined production of vero cytotoxin in strains of Escherichia coli serogroup O157 [Letter]. Lancet. 1984;1:1242-3.
133. Smith HW, Green P, Parsell Z. Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol. 1983;129:3121-37.
134. Garch H, Meyer T, Russmann H, Heesemann J. Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun. 1992;60:3464-7.
135. Beery JT, Doyle MP, Higley NA. Cytotoxic activity of Escherichia coli O157:H7 culture filtrate on the mouse colon and kidney. Current Microbiology. 1983;11:335-42.
136. Beery JT, Doyle MP, Schoeni JL. Colonization of chicken cecae by Escherichia coli associated with hemorrhagic colitis. Appl Environ Microbiol. 1985;49:310-5.
137. Farmer JJ 3d, Potter ME, Riley LW, Barren TJ, Blake PA, Bopp CA, et al. Animal models to study Escherichia coli O157:H7 isolated from patients with haemorrhagic colitis [Letter]. Lancet. 1983;1:702-3.
138. Francis DH, Collins JE, Duimstra JR. Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis. Infect Immun. 1986;51:953-6.
139. Pai CH, Kelly JK, Meyers GL. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun. 1986;51:16-23.
140. Potter ME, Kaufmann AF, Thomason BM, Blake PA, Farmer JJ 3d. Diarrhea due to Escherichia coli O157:H7 in the infant rabbit. J Infect Dis. 1985;152:1341-3.
141. Tzipori S, Wachsmuth IK, Chapman C, Birden R, Brittingham J, Jackson C, et al. The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets. J Infect Dis. 1986; 154:712-6.
142. Karmali MA, Petric M, Lim C, Fleming PC, Steele BT. Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis [Letter], Lancet. 1983;2:1299-300.
143. Marques LR, Moore MA, Wells JG, Wacbsmuth IK, O'Brien AD. Production of Shiga-like toxin by Escherichia coli. J Infect Dis. 1986; 154:338-41.
144. Obrig TG, Del Vecchio PJ, Karmali MA, Petric M, Moran TP, Judge TK. Pathogenesis of haemolytic uraemic syndrome [Letter]. Lancet. 1987;2:687.
145. Richardson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, et al. Experimental verocytotoxemia in rabbits. Infect Immun. 1992; 60:4154-67.
146. Karch H, Bitzan M. Pietsch R, Stenger KO, von Wulffen H, Heesemann J, et al. Purified verotoxins of Escherichia coli O157:H7 decrease prostacyclin synthesis by endothelial cells. Microb Pathog. 1988;5:215-21.
147. Rose PE, Armour JA, Williams CE, Hill FG. Verotoxin and neuramínídase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of haemolytic uraemic syndrome. J Clin Pathol. 1985;38:438-41.
148. Dykstra SA, Moxley RA, Janke BH, Nelson EA, Francis DH. Clinical signs and lesions in gnotobiotic pigs inoculated with Shiga-like toxin I from Escherichia coli. Vet Pathol. 1993;30:410-7.
149. Karch H, Heesemann J, Laufs R, O'Brien AD, Tacket CO, Levine MM. A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun. 1987;55:455-61.
150. Sherman P, Soni R, Petric M, Karmali M. Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7. Infect Immun. 1987;55:1824-9.
151. Sherman PM, Soni R. Adherence of Vero cytotoxin-producing Escherichia coli of serotype O157:H7 to human epithelial cells in tissue culture: role of outer membranes as bacterial adhesins. J Med Microbiol. 1988;26:11-7.
152. Toth I, Cohen ML, Rumschlag HS, Riley LW, White EH, Carr JH, et al. Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun. 1990;58: 1223-31.
153. Tripoli S, Karch H, Wachsmuth KI, Robins-Browne RM, O'Brien AD, Lier H, et al. Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets. Infect Immun. 1987; 55:3117-25.
154. Wells JG, Davis BR, Wachsmuth IK, Riley LW, Remis RS, Sokolow R, et al. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol. 1983;18:512-20.
155. Farmer JJ 3d, Davis BR. H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol. 1985; 22:620-5.
156. March SB, Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol. 1986;23:869-72.
157. Doyle MP, Schoeni JL. Survival and growth characteristics of Escherichia coli associated with hemorrhagic colitis. Appl Environ Microbiol. 1984;48:855-6.
158. Haldane DJ, Damm MA, Anderson JD. Improved biochemical screening procedure for small clinical laboratories for vero (Shigalike-)-toxin-producing strains of Escherichia coli O157:H7. J Clin Microbiol. 1986;24:652-3.
159. Ratnam S, March SB, Abmed R, Bezanson GS, Kasatiya S. Characterization of Escherichia coli serotype O157:H7. J Clin Microbiol. 1988;26:2006-12.
160. Thompson JS, Hodge DS, Borczyk AA. Rapid biochemical test to identify verocytotoxin-positive strains of Escherichia coli serotype O157. J Clin Microbiol. 1990;28:2165-8.
161. Gunzer F, Bohm H, Russman H, Bitzan M, Aleksic S, Karch H. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J Clin Microbiol. 1992;30: 1807-10.
162. Krishnan C, Fitzgerald VA, Dakin SJ, Benme RJ. Laboratory investigation of outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7. J Clin Microbiol. 1987;25:1043-7.
163. Chapman PA. Evaluation of commercial latex slide test for identifying Escherichia coli O157. J Clin Pathol. 1989;42:1109-10.
164. March SB, Ratnam S. Latex agglutination test for detection of Escherichia coli serotype O157. J Clin Microbiol. 1989;27:1675-7.
165. Tison DL. Culture confirmation of Escherichia coli serotype O157:H7 by direct immunofluorescence. J Clin Microbiol. 1990;28:612-3.
166. Downes FP, Barrett TJ, Green JH, Aloisio CH, Spika JS, Strockbine NA, et al. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies. Infect Immun. 1988;56:1926-33.
167. Karmali MA, Petric M, Lim C, Cheung R, Arbus GS. Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J Clin Microbiol. 1985;22:614-9.
168. Strockbine NA, Marques LR, Holmes RK, O'Brien AD. Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun. 1985;50:695-700.
169. Brown JE, Sethabutr O, Jackson MP, Lolekha S, Echeverria P. Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes. Infect Immun. 1989;57:2811-4.
170. Newland JW, Neill RJ. DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages. J Clin Microbiol. 1988;26:1292-7.
171. Karch H, Meyer T. Evaluation of oligonucleotide probes for identification of Shiga-like-toxin-producing Escherichia coli. J Clin Microbiol. 1989;27:1180-6.
172. Seriwatana J, Brown JE, Echeverria P, Taylor DN, Suthienkul O, Newtand J. DNA probes to identify Shiga-like toxin I- and II-producing enteric bacterial pathogens isolated from patients with diarrhea in Thailand. J Clin Microbiol. 1988;26:1614-5.
173. Willshaw GA, Smith HR, Scotland SM, Field AM, Rowe B. Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol. 1987;133:1309-17.
174. Acheson DW, Keusch GT, Lightowlers M, Donohue-Rolfe A. Enzymelinked immunosorbent assay for Shiga toxin and Shiga-like toxin II using P1 glycoprotein from hydatid cysts. J Infect Dis. 1990;161:134-7.
175. Ashkenazi S, Cleary TG. A method for detecting Shiga toxin and Shiga-like toxin-I in pure and mixed culture. J Med Microbiol. 1990; 32:255-61.
176. Downes FP, Green JH, Greene K, Strockbine N, Wells JG, Wachsmuth IK. Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II. J Clin Microbiol. 1989;27:1292-7.
177. Perera LP, Marques LR, O'Brien AD. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Eschenchia coil and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay, J Clin Microbiol. 1988;26:2127-31.
178. 3), their natural receptor. J Clin Microbiol. 1989;27:1145-50.
179. Pollard OR, Johnson WM, Lior H, Tyler SD, Rozee KR. Rapid and specific detection of verotoxin genest in Eschenchia colt by the polymerase chain reaction. J Clin Microbiol. 1990;28:540-5.
180. Brian MJ, Frosolono M, Murray BE Miranda A, Lopez EL, Gomez HF, et al. Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome. J Clin Microbiol. 1992;30:1801-6.
181. Paton AW, Paton JC, Goldwater PN, Manning PA. Direct detection of Escherichia coli Shiga-like toxin genes in primary fecal cultures by polymerase chain reaction. J Clin Microbiol. 1993;31:3063-7.
182. Kerch H, Meyer T. Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction. J Clin Microbiol. 1989;27:2751-7.
183. Tarr PI, Neill MA, Clausen CR, Newland JW, Neill RJ, Moseley SL. Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987. J Infect Dis. 1989;159:344-7.
184. Thomas A, Smith HR, Rowe B. Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Eschenchia coli strains of serogroup O157. J Clin Microbiol. 1993;31:1700-3.
185. Paros M, Tarr PI, Kim H, Besser TE, Hancock DD. A comparison of human and bovine Eschenchia coli O157:H7 isolates by toxin genotype, plasmid profile, and bacteriophage lambda-restriction fragment length polymorphism profile. J Infect Dis. 1993;168:1300-3.
186. Ahmed R, Bopp C, Borczyk A, Kasatiya S. Phage-typing scheme for Escherichia coli O157:H7. J Infect Dis. 1987; 155:806-9.
187. Khakhria R, Duck D, Lior H. Extended phage typing scheme for Escherichia coli O157:H7. Epidemiol Infect. 1990;105:511-20.
188. Samadpour M, Grimm LM, Desai B, Alfi D, Ongerth JE, Tarr PI. Molecular epidemiology of Escherichia coli O157:H7 strains by bacteriophage lambda restriction fragment length polymorphism analysis: application to a multistate food-borne outbreak and a day-care center cluster. J Clin Microbiol. 1993;31:3179-83.
189. Whittam TS, Wachsmuth IK, Wilson RA. Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic-uremic syndrome. J Infect Dis. 1988;157:1124-33.
190. Bohm H, Karch H. DNA fingerprinting of Escherichia coli O157:H7 strains by pulsed-field gel electrophoresis. J Clin Microbiol. 1992;30: 2169-72.
191. Chart H, Scotland SM, Smith HR, Rowe B. Antibodies to Escherichia coli O157 in patients with hemorrhagic colitis and haemolytic uraemic syndrome. J Clin Pathol. 1989;42:973-6.
192. Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet. 1991;337:138-40.
193. Padhye NV, Doyle MP. Production and characterization of a monoclonal antibody specific for enterohemorrhagic Eschenchia coli serotypes O157:H7 and O26:H11. J Clin Microbiol. 1991;29:99-103.
194. Yamada S, Matsushita S, Kai A, Sasaki M, Tsuji A, Kanemitsu T, et al. Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Eschenchia coli O157:H7. Microbiol Immunol. 1993;37:111-8.
195. Bitzan M, Moebios E, Ludwig K, Muller-Wiefel DE, Heesemann J, Karch H. High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr. 1991;119:380-5.
196. Tarr PL Neill MA, Christie DL, Anderson DE. Escherichia coli O157:H7 hemorrhagic colitis [Letter]. N Engl J Med. 1988;318:1697.
197. Kim HH, Semadpour M, Grimm L, Clausen CR, Besser TE, Baylor M, et al. Characteristics of antibiotic-resistant Escherichia coli O157:H7 in Washington State, 1984-1991. J Infect Dis. 1994; 170:1606-9.
198. Karch H, Strockbine NA, O'Brien AD. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay. FEMS Microbiol Lett. 1986;35:141-5.
199. Wallerspiel JN, Ashkenazi S, Morrow AL, Cleary TG. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection. 1992;20:25-9.
200. Proolx F, Turgeon JP, Delage G, Lafleur L, Chicoine L. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. J Pediatr. 1992;121:299-303.
201. Pichler HE, Diridl G, Stickler K, Wolf D. Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea. Am J Med. 1987;82:329-32.
202. MacDonald KL, Osterholm MT. The Emergence of Escherichia coli O157:H7 infection in the United States. The changing epidemiology of food-home disease [Editorial]. JAMA. 1993;269:2264-6.
203. Line JE, Fain A Jr, Moran AB. Lethality of heat to Escherichia coli O157:H7: D-value and Z-value determinations in ground beef. Journal of Food Protection. 1991;54:762-6.
204. Dytoc M, Soni R, Cockerill F 3d, De Azavedo J, Louie M, Brunton J, et al. Multiple determinants of verotoxin-producing Escherichia coli O157:H7 attachment-effacement. Infect Immun. 1993;61:3382-91.
205. Sherman P, Cockerill F 3d, Soni R, Brunton J. Outer membranes are competitive inhibitors of Escherichia coli O157:H7 adherence to epithelial cells. Infect Immun. 1991;59:890-9.
206. Yu J, Kaper JB. Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol. 1992; 6:411-7.
207. Louie M, de Azavedo JC, Handelsman MY, Clark CG, Ally B, Dytoc M, et al. Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7. Infect Immun. 1993;61:4085-92.
208. Schmidt H, Russmann H, Karch H. Virulence determinants in nontoxinogenic Escherichia coli O157 strains that cause infantile diarrhea. Infect Immun. 1993;61:4894-8.
209. Fitzpatrick MM, Dillon MJ. Current views on aetiology and management of haemolytic uraemic syndrome. Postgrad Med J. 1991;67: 707-9.
210. Loirat C, Sonsino E, Hinglais N, Jais JP, Landais P, Fennanian J. Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol. 1988;2:279-85.
211. Ogborn MR, Crocker JF, Barnard DR Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada. Can Med Assoc J. 1990;143:1323-6.
212. Rizzoni G, Claris-Appiani A, Edefonti A, Facchin P, Franchini F, Gusmano R, et al. Plama infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr. 1988;112: 284-90.
213. Robson WL, Fick GH, Jadavji T, Leung AK. The use of intravenous gammaglobulin in the treatment of typical hemolytic-uremic syndrome. Pediatr Nephrol. 1991;5:289-92.
214. Siegler RL. Management of hemolytic-uremic syndrome. J Pediatr. 1988;112:1014-20.
215. Havens PL, Dunne WM, Bord EM. Effects of human intravenous immune globulin on diarrhea caused by Shiga-like toxin J and Shiga-like toxin II in infant rabbits. Microbiol Immunol. 1992;36:1077-85.
216. Voelker R. New strategies aimed at E O157:H7. JAMA. 1994;272: 503.
217. Sandvig K, Brown JE. Ionic requirements for entry of Shiga toxin for Shigella dysenteriae 1 into cells. Infect Immun. 1987;55:298-303.